Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016-2019): a retrospective database study.

ABSTRACT:

Objective

Few epidemiological studies are reported in the published literature on the incidence or prevalence of antiphospholipid syndrome (APS), and available results are heterogeneous. This study aimed to estimate the incidence and prevalence of APS in the USA, overall and by APS subtype.

Design

A retrospective analysis of APS disease incidence and a cross-sectional analysis of disease prevalence.

Setting

Merative MarketScan Commercial Claims and Encounters Database, and the Medicare Supplemental and Coordination of Benefits Database.

Participants

All individuals with claims for at least two antiphospholipid antibody tests undertaken at least 12 weeks apart and a diagnosis claim for APS as a primary or secondary diagnosis on or after the second antibody test,

SUBMITTER: Khellaf M 

PROVIDER: S-EPMC11647356 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature